Lv1
20 积分 2025-04-23 加入
Preclinical Characterization of Catabolic Pathways and Metabolism of ABBV-011, a Novel Calicheamicin-Based SEZ6-Targeting Antibody-Drug Conjugate
3天前
已完结
Preclinical Evaluation of IMGC936, a Next-Generation Maytansinoid-based Antibody–drug Conjugate Targeting ADAM9-expressing Tumors
2个月前
已完结
Exploiting regulatory T cells (Tregs): Cutting-edge therapy for autoimmune diseases
3个月前
已完结
Atopic dermatitis: an expanding therapeutic pipeline for a complex disease
3个月前
已完结
mRNA display for the selection and evolution of enzymes from in vitro-translated protein libraries
3个月前
已完结
A PD-1-targeted, receptor-masked IL-2 immunocytokine that engages IL-2Rα strengthens T cell-mediated anti-tumor therapies
4个月前
已完结
Development of Sensitive Immunoassays for Free and Total Human Glandular Kallikrein 2
5个月前
已完结
OA10.06 Impact of Brain Metastases on Safety and Efficacy of MK-6070, a DLL3-Targeting T Cell Engager, in Small Cell Lung Cancer
5个月前
已完结
OP0195 EFFICACY AND SAFETY OF SONELOKIMAB, A NOVEL IL-17A- AND IL-17F-INHIBITING NANOBODY®, IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS (PsA): RESULTS FROM THE GLOBAL, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2 ARGO TRIAL
5个月前
已完结
皖公网安备34019202002308
